Does Trial Participation Improve Outcomes for Higher-Risk Myelodysplastic Syndromes (MDS) Patients Treated at Specialty Centers?

著录项

• 来源
  《Blood: The Journal of the American Society of Hematology》 |2018年第novaelatreatmentappr期|共3页
• 作者

  Mukherjee Sudipto; Steensma David P.; Komrokji Rami S.; DeZern Amy E.; Roboz Gail J.; Garcia-Manero Guillermo; Nazha Aziz; Maciejewski Jaroslaw P.; Sekeres Mikkael A.; Hobbs Brian P.; Jia Xuefei;

  展开▼
• 作者单位

  Cleveland Clin Taussig Canc Inst Dept Hematol &

  Med Oncol Leukemia Program Cleveland OH 44106;

  Dana Farber Canc Inst Boston MA 02115 USA;

  H Lee Moffitt Canc Ctr &

  Res Inst Dept Malignant Hematol Tampa FL USA;

  Johns Hopkins Univ Sidney Kimmel Comprehens Canc Ctr Baltimore MD USA;

  Cornell Univ Weill Cornell Med New York NY 10021 USA;

  Univ Texas MD Anderson Canc Ctr Dept Leukemia Houston TX 77030 USA;

  Cleveland Clin Cleveland OH 44106 USA;

  Cleveland Clin Fdn Taussig Canc Inst Dept Translat Hematol &

  Oncol Res 9500 Euclid Ave;

  Cleveland Clin Taussig Canc Inst Dept Hematol &

  Med Oncol Leukemia Program Cleveland OH 44106;

  Cleveland Clin Taussig Canc Inst Dept Hematol &

  Med Oncol Canc Biostat Cleveland OH 44106 USA;

  Cleveland Clin Quantitat Hlth Sci Cleveland OH 44106 USA;

  展开▼
• 收录信息
• 原文格式 PDF
• 正文语种 eng
• 中图分类 血液及淋巴系疾病;
• 关键词